SEPN
Septerna, Inc. Common Stock
Nasdaq · usd
Septerna, Inc. Common Stock (SEPN) trades at $40.02 (-3.96%) as of 7:40:59 PM EST on Nov 17, 2026, +10.01% over the past month. Market cap is $1.98B, with 11.9 days to cover in short interest.
Stock performance
How Septerna, Inc. Common Stock (SEPN) stock has performed from one day to one year, with its 52-week range.
- 1D
- -3.96%
- 1W
- -23.54%
- 1M
- +10.01%
- YTD
- +43.54%
- 1Y
- +84.51%
- 52-wk range
- $21.31 – $53.34
Key statistics
Today's trading snapshot for SEPN: day range, open, previous close, volume and market cap.
- Day range
- $39.28 – $41.67
- Open
- $41.67
- Prev close
- $41.67
- Volume
- 271.76K
- Market cap
- $1.98B
- Shares out
- 47.55M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Septerna, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 20.58
- P/B
- 4.63
- P/FCF
- —
- ROE
- -13.8%
- ROA
- -9.5%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 16, 2026
8-K filings
Material corporate events Septerna, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 9, 2026
On November 09, 2026, Septerna, Inc. (the "Company") announced its financial results and business highlights for the quarter ended September 30, 2026.
- Business updateNov 4, 2026
On November 4, 2026, Septerna, Inc. issued a press release titled "Septerna Announces Selection of SEP-204 as Development Candidate for Graves' Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting."
- Executive officer appointmentAug 25, 2026
Effective August 24, 2026, the Company's Board of Directors appointed Rajiv Patni, M.D., as the Company's Chief Medical Officer.
- Annual meeting resultsJun 30, 2026
The Company's stockholders elected Shalini Sharp, M.B.A. and Jake Simson, Ph.D. to the Company's Board of Directors (the "Board") as Class II directors, each for a three-year term ending at the annual meeting of stockholders of the Company to be held in 2029. The results of the stockholders' vote with respect to the election of the Class II directors were as follows: [vote tallies provided].
- Investor presentationApr 13, 2026
The Company also updated its corporate presentation for use in meetings with investors, analysts and others. A copy of the updated corporate presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K.
SEPN short interest
How heavily SEPN is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 11.9
- Short interest
- 3.35M
- Avg volume
- 280.56K
As of · reported to FINRA twice monthly.
SEPN news
The latest news and headlines about Septerna, Inc. Common Stock (SEPN).
- Septerna, Inc. (SEPN) Reports Q3 Loss, Lags Revenue EstimatesnegativeZacks Investment Research· Nov 9, 2026
- Moderna (MRNA) Q3 Earnings and Revenues Top EstimatespositiveZacks Investment Research· Nov 6, 2026
- Puma Biotech (PBYI) Tops Q3 Earnings EstimatesneutralZacks Investment Research· Nov 5, 2026
- Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)positiveGlobeNewswire Inc.· Sep 10, 2026
- Septerna to Participate in Upcoming Investor ConferencespositiveGlobeNewswire Inc.· Sep 1, 2026
Frequently asked questions
What is the Septerna, Inc. Common Stock (SEPN) stock price today?
Septerna, Inc. Common Stock (SEPN) is trading at $40.02 (-3.96% on the day) as of 7:40:59 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Septerna, Inc. Common Stock?
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform.
What is the short interest in SEPN?
As of Oct 30, 2026, SEPN has 3.35M shares short and 11.9 days to cover.
What exchange is SEPN listed on?
Septerna, Inc. Common Stock (SEPN) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of SEPN with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a SEPN analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.